Perfusion Systems Market - By Technique (Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By Component (Oxygenators, Heart-Lung Machine, Perfusion Pumps, Monitoring System), By Application, By End-use & Forecast, 2024 – 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationPerfusion Systems Market - By Technique (Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By Component (Oxygenators, Heart-Lung Machine, Perfusion Pumps, Monitoring System), By Application, By End-use & Forecast, 2024 – 2032
Perfusion Systems Market Size
In 2023, the market for perfusion systems was worth over $1.35 billion. By 2032, it is expected to grow by 4.5% each year. This growth is being fueled byMore people getting heart and lung diseases New technology in perfusion systems An increase in the number of people with multiple organ failure, especially among the elderly More organ transplants The growing use of perfusion technology in drug discovery, tissue engineering, and regenerative medicine The increased demand for biologics and personalized medicine
In recent years, perfusion systems have undergone a transformative evolution. Technological advancements have propelled these systems to new heights, enabling them to operate with greater efficiency, expand in size, and enhance their autonomy. Through the integration of sophisticated sensors and control systems, perfusion systems now offer exceptional monitoring capabilities, allowing researchers and clinicians to closely track and regulate the growth of cells and tissues. This precision control has paved the way for more accurate and accelerated cell and tissue culture. The aging population has heightened the demand for perfusion systems. As the incidence of chronic diseases and organ failure escalates, so too does the need for innovative therapies. Organs grown in perfused systems present a promising solution, offering potential treatments for a spectrum of conditions. The convergence of factors, including the growing awareness of organ donation, increased healthcare accessibility, and technological progress, is driving rapid growth within the perfusion systems industry. As the field continues to advance, it holds immense promise for revolutionizing the diagnosis and management of heart conditions, expanding the pool of available organs, and unlocking the full potential of tissue engineering.
Perfusion systems are specialized medical devices intended to support the growth and maintenance of cell cultures or tissues outside the natural environment. These systems provides a controlled environment with a continuous flow of oxygen, nutrients, growth factors, and other essential components necessary for their survival and optimal function of the cells and tissue.
| Report Attribute | Details |
|---|---|
| Base Year | 2023 |
| Perfusion Systems Market Size in 2023 | USD 1.35 Billion |
| Forecast Period | 2024 to 2032 |
| Forecast Period 2024 to 2032 CAGR | 4.5% |
| 2032 Value Projection | USD 2.02 Billion |
| Historical Data for | 2018 to 2023 |
| No. of Pages | 180 |
| Tables, Charts & Figures | 357 |
| Segments covered | Technique, Component, Application, End-use, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
The hefty price tag of perfusion systems can be a major roadblock, especially for cash-strapped research labs, universities, and hospitals. With limited budgets, they may have to put their perfusion equipment dreams on hold. This could slow down the growth of the perfusion market. Similarly, developing countries and regions might not have enough money to splash out on these expensive systems, which could also put a damper on the market's expansion in those areas.
Moreover, the value proposition of perfusion systems, such as improved productivity, better control over culture conditions, and enhanced product quality, has increased the cost of these systems incrementally.
COVID-19 Impact
The arrival of COVID-19 in early 2020 sent shockwaves through businesses globally, including the healthcare industry. As the virus ravaged communities, hospitals and clinics struggled to manage the surge in patients, straining their capacity. This strain trickled down to the sales of perfusion systems, vital equipment used to treat heart and lung conditions. With people hesitant to visit medical facilities for fear of infection, routine checkups and treatments were postponed. Even life-saving procedures like organ transplants and surgeries were placed on hold. Adding to the woes of the perfusion systems industry was the disruption of supply chains. Manufacturers faced difficulties sourcing essential components, and shipping delays hampered the timely delivery of equipment to hospitals in dire need. These combined factors created a gloomy outlook for the growth of the perfusion systems market.
Restrictions on international trade, lockdown measures, and reduced workforce availability have affected the timely availability of components and raw materials necessary for manufacturing perfusion systems. These disruptions have slowed down production and hindered market growth. The pandemic has disrupted clinical trial activities, with many trials being postponed or halted due to safety concerns, limited patient access, and overwhelmed healthcare systems. The COVID-19 pandemic resulted in a precipitous decline in hospitalizations of chronic ailments. Due to the pandemic, many healthcare systems and hospitals had to prioritize resources and focus on treating COVID-19 patients.
As a result, elective procedures were often postponed or canceled. Thus, the COVID-19 pandemic had a negative impact on the perfusion systems market during 2020 which gained impetus in the later stages during 2021. Reducing COVID-19 infection rates and patients, as well as increased procedural volume, are expected to aid market growth in the approaching years.
Perfusion Systems Market Trends
Increasing prevalence of cardiovascular and respiratory diseases is anticipated to drive the market growth. Cardiovascular and respiratory diseases often lead to tissue damage and organ dysfunction. For instance, according to the Global Initiative for Chronic Obstructive Lung Disease – GOLD, in 2020, the incidence rate of lung cancer was around 2.2 million individuals and is forecasted to increase in the near future. Perfusion systems play a crucial role in the diagnosis and treatment of lung cancer and other chronic ailments by providing a controlled environment for the growth and development of tissues and organs for transplantation.
The increasing prevalence of cardiovascular and respiratory diseases drives the demand for tissue engineering and regenerative medicine, thereby boosting the perfusion systems market for perfusion systems. There is an increasing focus on personalized medicine, tailoring treatments to individual patients' specific characteristics. Perfusion systems play a role in this approach by facilitating the culture and testing of patient-specific cells or tissues for diagnosis and treatment optimization.
With cardiovascular and respiratory diseases being diverse in nature and manifestation, the demand for personalized medicine is set to grow, driving the utilization of perfusion systems. The treatment of cardiovascular and respiratory diseases often involves the use of biologics, such as therapeutic proteins, cell therapies, and gene therapies. Perfusion systems are integral to the bioprocessing of these products, ensuring optimal cell growth, viability, and productivity. Therefore, as the burden of cardiovascular and respiratory diseases continues to rise, the demand for advanced technologies in perfusion systems is anticipated to propel the market growth.
Perfusion Systems Market Analysis
Based on technique, the market is segmented as hypothermic machine perfusion, normothermic machine perfusion. The hypothermic machine perfusion dominated the perfusion systems market accounting over 65% business share in 2022. The increasing demand for hypothermic machine perfusion (HMP) can be attributed to several factors that drive the adoption and utilization of perfusion systems. HMP plays a vital role in organ preservation for transplantation, particularly for complex organs like the liver, kidney, and heart. It allows for extended preservation times compared to traditional static cold storage, reducing ischemic damage, and improving organ viability.
The increasing demand for organ transplantation, coupled with the need to improve transplant outcomes, drives the adoption of hypothermic machine perfusion. HMP permits for dynamic assessment of organ function and viability before transplantation. By continuously perfusing and monitoring the organ, HMP provides real-time data on parameters such as oxygen consumption, metabolic activity, and organ function. HMP enables the use of specialized preservation solutions that are continuously circulated through the organ during preservation.
In the heart of cardiac surgeries, a team of machines works tirelessly to keep patients alive. Among them, oxygenators take center stage. Just like our lungs, they breathe for patients while surgeons mend their hearts. Oxygenators are no mere bystanders; they play a crucial role in removing carbon dioxide and pumping oxygen into the blood, sustaining life during surgery. Their importance is reflected in the booming market. In 2022 alone, oxygenators generated a staggering $400 million. Why this surge in demand? As heart surgeries become more prevalent, so does the need for oxygenators. They're indispensable in ECMO machines, breathing for patients with weakened lungs. With the increasing number of lives dependent on these machines, the oxygenator market shows no signs of slowing down.
With the rising prevalence of respiratory diseases and the need for advanced life support, the demand for oxygenators has been increasing, contributing to the growth of the perfusion systems market. Technological advancements have improved the design and performance of oxygenators significantly. Enhanced oxygen transfer capabilities, reduced priming volumes, and improved biocompatibility are some of the advancements that make oxygenators more efficient and reliable. These advancements coupled with ageing population, drives the adoption of oxygenators thereby fuelling industry growth.
Imagine yourself in the hospital, facing a life-saving heart surgery. Your heart, the vital engine that keeps you alive, must be temporarily stopped during the procedure. But how can you survive without a beating heart? That's where perfusion systems step in, like lifelines, keeping you alive while your heart takes a break. There are different types of perfusion systems, but let's talk about the cardiopulmonary perfusion system, the one that keeps your heart and lungs functioning during surgery. Think of it as a temporary stand-in for your heart and lungs. It pumps oxygen-rich blood throughout your body, giving your tissues the vital nourishment they need while your heart rests. It's like a lifeline, ensuring your body doesn't suffer while the surgeons work their magic. This system is essential for surgeries that fix clogged arteries, repair damaged heart valves, or correct birth defects in your heart. As more and more people require these life-saving procedures, the demand for cardiopulmonary perfusion systems is steadily increasing. Experts predict that the market will grow by about 4.7% each year until 2032, highlighting the growing importance of these vital systems in the fight against heart disease.
The global burden of cardiovascular diseases, including conditions such as coronary artery disease, heart failure, and valvular diseases, continues to rise. Additionally, advancements in healthcare infrastructure and accessibility to advanced medical facilities in developing countries have led to an increased demand for cardiac surgeries. Cardiopulmonary perfusion systems help maintain stable physiological conditions during cardiac surgeries, reducing the risk of complications and improving patient outcomes.
Hospitals are the primary customers for perfusion systems, investing heavily in them to provide life-saving support during heart surgeries. In 2022 alone, hospitals spent a substantial $623 million on these systems. This investment reflects the crucial role perfusion systems play in enabling heart surgeons to perform complex procedures like bypass grafting, valve replacements, and birth defect repairs. During these critical operations, perfusion systems take on the vital tasks of the heart and lungs, keeping the patient's blood flowing and oxygenated. As the number of heart surgeries continues to rise, so does the demand for perfusion systems in hospitals. These systems are not only essential for ensuring patients' survival during surgery but also enhance their recovery and quality of life afterward.
Hospitals are getting fancy with their surgeries! They're using these cool gadgets that let them make tiny cuts, which is way better for patients than those big old scars. Even organ transplants are getting high-tech with these special machines that keep organs alive and kicking before they find a new home. More and more people are struggling with long-term health issues these days, so hospitals are doubling down on making it easier for them to get the care they need. That means having the right tools and the best and brightest doctors and nurses to use them. These fancy machines and treatments are making hospitals more like one-stop shops for people with chronic conditions. It's like a game-changer! Not only are patients getting the help they need, but hospitals are also getting a boost in cash because more people are coming through their doors. Win-win!
Hey there, have you heard about perfusion systems? They're like the cool gadgets that keep blood flowing during heart and lung surgeries. And guess what? North America is the superstar in this field. They're raking in the big bucks, with a whopping $477 million in 2022 alone! Why's that? Here's the scoopMajor companies in the industry are setting up shop in North America. Heart and lung problems are on the rise, especially among our older folks. Cardiovascular diseases are widespread there, including heart attacks and valve issues. And here's the kickerperfusion systems are the unsung heroes of these surgeries. They're like the trusty sidekicks that ensure blood keeps flowing during critical procedures like heart bypass and valve repairs.
Hello! Doctors and nurses in North America are all excited about the latest technology for keeping patients comfortable and steady during surgery. These perfusion systems have gotten smarter and more efficient, making them a game-changer in the operating room. And guess what? Hospitals and clinics in North America have a big advantage because insurance companies and the government are willing to pay for these systems. This means they can invest in the latest and greatest equipment. With lots of people in the region needing heart surgeries, and with companies constantly developing new and improved perfusion technologies, North America is becoming the go-to place for these state-of-the-art systems.
Perfusion Systems Market Share
Some of the major players operating in the perfusion systems market are
- ALA Scientific Instruments, Inc.
- Bioptechs Inc.
- Cytiva
- Getinge AB
- Harvard Bioscience, Inc.
- Lifeline Scientific, Inc
- LivaNova
- Medtronic, plc
- Merck KGaA
- Nipro Corporation
- Repligen Corporation
- Spectrum Laboratories, Inc.
- Terumo Corporation
- XENIOS AG
- XVIVO Perfusion AB
These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
Perfusion Systems Industry News
- In February 2023, LivaNova PLC announced the launch of Essenz Perfusion System for cardiopulmonary bypass procedures in Europe. This systems incorporates advance heart-lung machine and a transformative patient monitor during cardiopulmonary bypass (CPB) procedures. This innovative product launch helped the company to expand their geographic presence and increase their customer base thereby generating business revenue.
- In September 2020, Cytiva announced the launch of Xcellerex Automated Perfusion System (APS) intended for upstream surgical procedures. This system is integrated with bioreactors for continuous upstream bioprocessing operations and is capable of automated filter switching, liquid management and cell bleed, that reduces risk for human error and increases process robustness. This strategic launch helped the company to increase their product portfolio and gain a competitive edge over its peers.
This perfusion systems market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By Technique
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
By Component
- Oxygenators
- Heart-Lung Machine
- Perfusion Pumps
- Monitoring System
- Bioreactor Perfusion System
- Others
By Application
- Cardiopulmonary Perfusion System
- Cell Perfusion System
- Ex-Vivo Organ Perfusion System
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Sweden
- The Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Thailand
- Philippines
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Peru
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Israel
- Egypt
- Turkey
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy